Institute of Medical Biotechnology Vector

The main purpose of the Institute of Medical Biotechnology:

Development of effective diagnostic, preventive and therapeutic agents necessary to ensure sanitary and epidemiological well-being of the Russian Federation, against infectious diseases of the viral nature of humans and animals, as well as diseases resulting from infections (immunodeficiency, allergic, oncological and other diseases) based on the achievements of biotechnology, genetic engineering, virology, immunology, molecular biology.

History

2022: The government allocated 1.09 billion rubles to Rospotrebnadzor for the study of infections in other countries

In early April 2022, an order signed by Prime Minister Mikhail Mishustin to allocate more than 1 billion rubles to Rospotrebnadzor to study infections outside Russia was published on the official Internet portal of legal information. More details here.

2019: The best Ebola vaccine in the world

In June 2019, Rospotrebnadzor introduced a unique Ebola vaccine.

The vaccine was shown at an international conference on Ebola vaccination, which was held in the DRC on June 28-29.

"The vaccine, presented by Rospotrebnadzor, was developed using the latest technologies by the state scientific center of virology and biotechnology" Vector. " This vaccine is peptide and significantly differs from the currently used Western analogues in the highest safety, lack of adverse reactions, convenience of storage, transportation and use, and, most importantly, gives effective protective immunity against deadly infection, "the agency said.

It is noted that the vaccine has passed all stages of state registration and is currently the safest and lowest-response vaccine produced in the world. In addition, according to the results of the presentation, the issue of the supply and use of the Russian EpiVaEbola vaccine in the DRC to combat the ongoing Ebola epidemic is being considered.